Articles From: Financial services providers failing to connect with millennial generation, according to new study by BNY Mellon & the University of Oxford to SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Altisource Portfolio Solutions SA to Contact Brower Piven Before the November 7, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- ASPS


TORONTO, Sept.
Sign-up for GreeneStone to Expand Focus on Addiction Treatment investment picks
AUSTIN, Texas, Sept.
Sign-up for EZCORP Names Eric Fosse to Lead Pawn Business investment picks
SAN RAFAEL, Calif., Sept.
Sign-up for BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines investment picks
SAN FRANCISCO, Sept.
Sign-up for Diamond Foods Announces Fourth Quarter and Full Fiscal Year 2014 Earnings Conference Call investment picks
STAMFORD, Conn., Sept.
Sign-up for Peerless Systems Announces Results for the Second Quarter Ended July 31, 2014 investment picks
ATLANTA, Sept.
Sign-up for Equifax to Meet With Boston Investors investment picks
AMSTERDAM, The Netherlands, Sept.
Sign-up for Dot Hill Announces Certification of AssuredSAN Storage Arrays With Blackmagic Design and Tiger Technology investment picks
NEW YORK, Sept.
Sign-up for Quarterly Changes to the NASDAQ Golden Dragon China Index investment picks
NEW YORK, Sept.
Sign-up for Semi-Annual Changes to the NASDAQ Clean Edge Green Energy Index investment picks
NEW YORK, Sept.
Sign-up for Semi-Annual Changes to the NASDAQ Technology Dividend Index investment picks
NEW YORK, Sept.
Sign-up for Quarterly Changes to the NASDAQ Q-50 Index investment picks
Overall Response Rate (ORR) to be the Primary Endpoint to Support Accelerated Approval with Progression-Free Survival (PFS) to Support Full Approval Safety and Efficacy Data from Over 30 CLL Patients from the On-going Phase 2 Trial of the Combination of TG-1101 plus ibrutinib Anticipated to be Presented at ASH 2014 NEW YORK, Sept.
Sign-up for TG Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA for Its First Phase 3 Clinical Trial of TG-1101 (ublituximab) in Combination With Imbruvica(R) (ibrutinib) for Patients With Previously Treated Chronic Lymphocytic Leukemia investment picks
CHATTANOOGA, Tenn., Sept.
Sign-up for Astec Industries, Inc. to Present at Credit Suisse 5th Annual Small & Mid Cap Conference investment picks
STATE COLLEGE, Pa., Sept.
Sign-up for Rex Energy Provides Update on Operations, Third Quarter Production Guidance and Borrowing Base investment picks
2014/9/15
ST. LOUIS, Sept.
Sign-up for Equifax Workforce Solutions Announces 50,000 Active CaseBuilder Users investment picks
SHANGHAI, China, Sept.
Sign-up for Mecox Lane Limited to Announce Second Quarter Results on September 18 investment picks
NEW YORK and CAIRO, Sept.
Sign-up for Photo Release -- The Egyptian Exchange (EGX) Extends Trading Technology Contract With NASDAQ OMX investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Financial services providers failing to connect with millennial generation, according to new study by BNY Mellon & the University of Oxford to SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Altisource Portfolio Solutions SA to Contact Brower Piven Before the November 7, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- ASPS
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent